Common Contracts
21 similar Equity Distribution Agreement contracts by NAKED BRAND GROUP LTD, Guardion Health Sciences, Inc., Inpixon, others
NEXALIN TECHNOLOGY, INC. Up to [●] Shares of Common Stock EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • April 16th, 2024 • Nexalin Technology, Inc. • Electromedical & electrotherapeutic apparatus • New York
Nexalin Technology, Inc., a Delaware corporation (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as exclusive sales agent, shares of common stock, par value $[●] per share (“Common Stock”), of the Company (the “Shares”) having an aggregate offering price of up to $[●] on terms set forth herein. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
The OLB Group, Inc. Up to $15,000,000 Shares of Common Stock EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • February 23rd, 2024 • Olb Group, Inc. • Services-business services, nec • New York
The OLB Group, Inc., a Delaware corporation (the “Company”), proposes to issue and sell through Maxim Group LLC, as sales agent (the “Agent”), shares (the “Shares”) of its common stock, par value $0.0001 per share (“Common Stock”), having an aggregate offering price of up to $15,000,000 on terms set forth in this Equity Distribution Agreement (this “Agreement”). The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
AIM ImmunoTech Inc. Up to $8,500,000 Shares of Common Stock Equity Distribution AgreementEquity Distribution Agreement • April 19th, 2023 • AIM ImmunoTech Inc. • Biological products, (no disgnostic substances) • New York
AIM ImmunoTech Inc., a Delaware corporation (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as sales agent, shares of common stock, par value $0.001 per share (“Common Stock”), of the Company (the “Shares”) having an aggregate offering price of up to $8,500,000 on terms set forth herein. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
IMPERIAL PETROLEUM INC. Up to US$50,000,000 of Shares of Common Stock EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • December 2nd, 2022 • Imperial Petroleum Inc./Marshall Islands • Deep sea foreign transportation of freight • New York
Imperial Petroleum Inc., a corporation organized under the laws of the Republic of the Marshall Islands (the “Company”), proposes to issue and sell through Maxim Group LLC (“Maxim”) and Virtu Americas LLC (“Virtu”, each an “Agent” and collectively, the “Agents”), as co-sales agents, shares of common stock of the Company, par value $0.01 per share (the “Common Stock”), having an aggregate offering price of up to US$50,000,000 of shares of Common Stock (the shares of Common Stock subject to this Equity Distribution Agreement (this “Agreement”) being referred to herein as the “Shares”) on terms set forth herein. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
Oxbridge Re Holdings Limited Up to $6,300,000 of Ordinary Shares (par value $0.001 per share) Equity Distribution AgreementEquity Distribution Agreement • September 30th, 2022 • OXBRIDGE RE HOLDINGS LTD • Fire, marine & casualty insurance • New York
Oxbridge Re Holdings Limited, a Cayman Islands exempted company (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as sales agent, ordinary shares, par value $0.001 per share (“Ordinary Shares”), of the Company having an aggregate offering price of up to $6,300,000 (the Ordinary Shares to be offered and sold subject to this Equity Distribution Agreement (this “Agreement”) being referred to herein as the “Shares”) on terms set forth herein. The Shares consist entirely of authorized but unissued Ordinary Shares to be issued and sold by the Company.
Lexaria Bioscience Corp. Up to $5,925,000 of Shares of Common Stock Equity Distribution AgreementEquity Distribution Agreement • August 12th, 2022 • Lexaria Bioscience Corp. • Pharmaceutical preparations • New York
Lexaria Bioscience Corp., a Nevada corporation (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as exclusive sales agent, shares of common stock, par value $0.001 per share (“Common Stock”), of the Company (the “Shares”) having an aggregate offering price of up to $5,925,000 on terms set forth herein. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
Guardion Health Sciences, Inc. Shares of Common Stock (par value $0.001 per share) Equity Distribution AgreementEquity Distribution Agreement • January 28th, 2022 • Guardion Health Sciences, Inc. • Pharmaceutical preparations • New York
Guardion Health Sciences, Inc., a Delaware corporation (the “Company”), proposes to issue and sell through Maxim Group LLC and Roth Capital Partners, LLC (each an “Agent” and collectively, the “Agents”), as co-sales agents, shares of common stock, par value $0.001 per share (“Common Stock”), of the Company on terms set forth herein. The Shares (as defined below) consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company. This Agreement is entered into in connection with that certain engagement letter, dated January 10, 2022 between the Company and the Agents (the “Engagement Letter”).
NUZEE, INC. Up to $20,000,000 of Common Stock EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • December 29th, 2021 • NuZee, Inc. • Retail-miscellaneous retail • New York
NuZee, Inc., a Nevada corporation (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as sales agent, shares of common stock, par value $0.00001 per share (the “Common Stock”), of the Company (the “Shares”) having an aggregate offering price of up to $20,000,000 on terms set forth herein. The Shares consist entirely of authorized but unissued Common Stock to be issued and sold by the Company.
Naked Brand Group Limited Up to $300,000,000 of Ordinary Shares Equity Distribution AgreementEquity Distribution Agreement • November 8th, 2021 • NAKED BRAND GROUP LTD • Men's & boys' furnishgs, work clothg, & allied garments • New York
Naked Brand Group Limited, a company incorporated under the laws of Australia (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as sales agent, ordinary shares, with no par value (“Ordinary Shares”), of the Company (the “Shares”) having an aggregate offering price of up to $300,000,000 on terms set forth herein. The Shares consist entirely of authorized but unissued Ordinary Shares to be issued and sold by the Company.
Naked Brand Group Limited Up to $99,500,000 of Ordinary Shares Equity Distribution AgreementEquity Distribution Agreement • February 25th, 2021 • NAKED BRAND GROUP LTD • Men's & boys' furnishgs, work clothg, & allied garments • New York
Naked Brand Group Limited, a company incorporated under the laws of Australia (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as sales agent, ordinary shares, with no par value (“Ordinary Shares”), of the Company (the “Shares”) having an aggregate offering price of up to $99,500,000 on terms set forth herein. The Shares consist entirely of authorized but unissued Ordinary Shares to be issued and sold by the Company.
Guardion Health Sciences, Inc. Shares of Common Stock (par value $0.001 per share) Equity Distribution AgreementEquity Distribution Agreement • January 8th, 2021 • Guardion Health Sciences, Inc. • Pharmaceutical preparations • New York
Guardion Health Sciences, Inc., a Delaware corporation (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as sales agent, shares of common stock, par value $0.001 per share (“Common Stock”), of the Company on terms set forth herein. The Shares (as defined below) consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
Vivopower International PLC Up to $50,000,000 of Ordinary Shares Equity Distribution AgreementEquity Distribution Agreement • December 11th, 2020 • VivoPower International PLC • Electric & other services combined • New York
Vivopower International PLC, a public limited company incorporated under the laws of England and Wales (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as sales agent, ordinary shares, nominal value $0.012 per share (“Ordinary Shares”), of the Company having an aggregate offering price of up to $50,000,000 on terms set forth herein (the “Shares”). The Shares consist entirely of authorized but unissued Ordinary Shares to be issued and sold by the Company.
Naked Brand Group Limited Up to $50,000,000 of Ordinary Shares Equity Distribution AgreementEquity Distribution Agreement • October 19th, 2020 • NAKED BRAND GROUP LTD • Men's & boys' furnishgs, work clothg, & allied garments • New York
Naked Brand Group Limited, a company incorporated under the laws of Australia (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as sales agent, ordinary shares, with no par value (“Ordinary Shares”), of the Company (the “Shares”) having an aggregate offering price of up to $50,000,000 on terms set forth herein. The Shares consist entirely of authorized but unissued Ordinary Shares to be issued and sold by the Company.
Naked Brand Group Limited Up to $5,000,000 of Ordinary Shares Equity Distribution AgreementEquity Distribution Agreement • August 20th, 2020 • NAKED BRAND GROUP LTD • Men's & boys' furnishgs, work clothg, & allied garments • New York
Naked Brand Group Limited, a company incorporated under the laws of Australia (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as sales agent, ordinary shares, with no par value (“Ordinary Shares”), of the Company (the “Shares”) having an aggregate offering price of up to $5,000,000 on terms set forth herein. The Shares consist entirely of authorized but unissued Ordinary Shares to be issued and sold by the Company.
Artelo Biosciences, Inc. Up to $3,000,000 of Shares of Common Stock Equity Distribution AgreementEquity Distribution Agreement • April 15th, 2020 • Artelo Biosciences, Inc. • Services-business services, nec • New York
Artelo Biosciences, Inc., a Nevada corporation (the "Company"), proposes to issue and sell through Maxim Group LLC (the "Agent"), as sales agent, shares of common stock, par value $0.001 per share ("Common Stock"), of the Company (the "Shares") having an aggregate offering price of up to $3,000,000 on terms set forth herein. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
Inpixon Up to $50,000,000 of Shares of Common Stock Equity Distribution AgreementEquity Distribution Agreement • March 3rd, 2020 • Inpixon • Services-computer programming services • New York
Inpixon, a Nevada corporation (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as exclusive sales agent, shares of common stock, par value $0.001 per share (“Common Stock”), of the Company (the “Shares”) having an aggregate offering price of up to $50,000,000 on terms set forth herein. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
SELLAS Life Sciences Group, Inc. Up to $5,000,000 Shares of Common Stock Equity Distribution AgreementEquity Distribution Agreement • October 31st, 2019 • SELLAS Life Sciences Group, Inc. • Pharmaceutical preparations • New York
SELLAS Life Sciences Group, Inc., a Delaware corporation (the "Company"), proposes to issue and sell through Maxim Group LLC (the "Agent"), as sales agent, shares of common stock, par value $0.0001 per share ("Common Stock"), of the Company (the "Shares") having an aggregate offering price of up to $5,000,000 on terms set forth herein. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
Inpixon Up to $6,500,000 Shares of Common Stock Equity Distribution AgreementEquity Distribution Agreement • October 11th, 2019 • Inpixon • Services-computer programming services • New York
Inpixon, a Nevada corporation (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as exclusive sales agent, shares of common stock, par value $0.001 per share (“Common Stock”), of the Company (the “Shares”) having an aggregate offering price of up to $6,500,000 on terms set forth herein. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
Hemispherx Biopharma, Inc. Up to $70,000,000 Shares of Common Stock Equity Distribution AgreementEquity Distribution Agreement • July 22nd, 2019 • Hemispherx Biopharma Inc • Biological products, (no disgnostic substances) • New York
Hemispherx Biopharma, Inc., a Delaware corporation (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as sales agent, shares of common stock, par value $0.001 per share (“Common Stock”), of the Company (the “Shares”) having an aggregate offering price of up to $70,000,000 on terms set forth herein. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
SINTX Technologies, Inc. Up to $1,600,000 Shares of Common Stock Equity Distribution AgreementEquity Distribution Agreement • June 4th, 2019 • Sintx Technologies, Inc. • Surgical & medical instruments & apparatus • New York
SINTX Technologies, Inc., a Delaware corporation (the “Company”), proposes to issue and sell through Maxim Group LLC (the “Agent”), as exclusive sales agent, shares of common stock, par value $0.01 per share (“Common Stock”), of the Company (the “Shares”) having an aggregate offering price of up to $1,600,000 on terms set forth herein. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
ARRAY BIOPHARMA INC. Common Stock Equity Distribution AgreementEquity Distribution Agreement • September 18th, 2009 • Array Biopharma Inc • Pharmaceutical preparations • New York
Array BioPharma Inc., a Delaware corporation (the “Company”), proposes to issue and sell through or to Piper Jaffray & Co. (the “Agent”), as sales agent and/or principal, shares of Common Stock, $0.001 par value per share (the “Common Stock”), of the Company having an aggregate offering price of up to $25,000,000 (the “Shares”) on terms set forth herein. The Company agrees that whenever it determines to sell the Shares directly to the Agent as principal, it will enter into a separate agreement (each, a “Terms Agreement”) in substantially the form of Annex A hereto, relating to such sale in accordance with this Agreement. The Shares consist entirely of authorized but unissued shares of Common Stock to be issued and sold by the Company.
